A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in ...

A new CRISPR-powered light sensor can detect the faintest whispers of cancer in a single drop of blood.

Is the Galleri multi-cancer blood test worth it? A doctor explains real-world performance data and explains why no major ...

A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...

MADISON, Wis., September 10, 2025 — Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer diagnostics, today announced the launch of the Cancerguard™ test, a new multi-cancer early detection (MCED) ...

Please provide your email address to receive an email when new articles are posted on . The study will evaluate whether two multicancer early detection tests improve early detection of 10 solid tumors ...

Cancer affects millions of people around the world every year. Oftentimes, the signs and symptoms of cancer present themselves once the disease has advanced into its later stages, leaving many wishing ...

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...

A four-biomarker blood panel of aminopeptidase N (ANPEP), polymeric immunoglobulin receptor (PIGR), CA19-9, and thrombospondin-2 (THBS2) enhanced the detection of pancreatic ductal adenocarcinoma ...